LEADER 04768nam  2200625Ia 450 
001 9910809037403321
005 20200520144314.0
010   $a1-61761-958-2
035   $a(CKB)2550000001040598
035   $a(EBL)3017722
035   $a(SSID)ssj0000826684
035   $a(PQKBManifestationID)12338724
035   $a(PQKBTitleCode)TC0000826684
035   $a(PQKBWorkID)10819476
035   $a(PQKB)11751357
035   $a(MiAaPQ)EBC3017722
035   $a(Au-PeEL)EBL3017722
035   $a(CaPaEBR)ebr10654693
035   $a(OCoLC)923653453
035   $a(EXLCZ)992550000001040598
100   $a20091229d2010      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCongestive heart failure $esymptoms, causes and treatment /$fJosias E. Garcia and Victoro R. Wright, editors
205   $a1st ed.
210   $aNew York $cNova Science Publishers$dc2010
215   $a1 online resource (244 p.)
225 1 $aCardiology research and clinical developments
300   $aDescription based upon print version of record.
311   $a1-60876-677-2 
320   $aIncludes bibliographical references and index.
327   $a""CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT""; ""CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT""; ""CONTENTS""; ""PREFACE""; ""MONITORING PULMONARY EDEMA IN CHF PATIENTS WITH A HYBRID BIO-IMPEDANCE APPROACH""; ""ABSTRACT""; ""1. PULMONARY EDEMA IN CHF PATIENTS a??? ORIGINS AND MEASURING TECHNIQUES""; ""2. THE BIO-IMPEDANCE APPROACH IN MEASURING PULMONARY EDEMA""; ""3. A HYBRID BIO-IMPEDANCE SYSTEM FOR DIAGNOSING AND MONITORING CHF PATIENTS""; ""3.1. Technical Design""; ""3.1.1. Hardware design""; ""3.1.2. Software design""; ""Lung resistivity estimation""
327   $a""RR and QT interval calculation""""3.2. Clinical Results""; ""3.2.1. Baseline measurements""; ""3.2.2. CHF patientsa??? classification and long-term monitoring""; ""3.2.3. Monitoring CHF patients under intravenous diuretics treatment""; ""3.2.4. Correlation between bio-impedance measurements and X-ray radiographs""; ""3.3. Monitoring CHF Patients at Home Via a Telemedicine Approach""; ""4. SUMMARY AND CONCLUSIONS""; ""REFERENCES""; ""THE ASSOCIATION BETWEEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS AND HEART FAILURE: A REVIEW OF PATHOGENESIS AND MANAGEMENT""; ""ABSTRACT""
327   $a""1. MADIT II AND SCD-HEFT: TWO MAJOR RANDOMIZED CONTROLLED TRIALS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY""""2. PATHOGENESIS OF HEART FAILURE IN PATIENTS WITH ICD SHOCKS""; ""The Effect of Shock: Appropriate and Inappropriate Shocks""; ""ICD Shocks and the Activation of Sympathetic Nervous System""; ""The Activation of Sympathetic Nervous System and the Psychiatric Consequences: Impact on Heart Failure Progression""; ""MANAGEMENT""; ""Patient Selection""; ""Optimal Medical Management of Heart Failure""; ""Device Programming""; ""Anti-Arrhythmic Medications, Including Amiodarone""
327   $a""Management of Psychiatric Symptoms and Syndromes""""Organized Protocol for Review of Patients Receiving ICD Shocks""; ""CONCLUSION""; ""REFERENCES""; ""REVERSIBLE LEFT VENTRICULAR DYSFUNCTION: THE TAKOTSUBO SYNDROME""; ""ABSTRACT""; ""INTRODUCTION""; ""Epidemiology""; ""Aetiology""; ""Clinical Features""; ""Diagnosis""; ""Laboratory Data""; ""Cardiac Biomarkers""; ""Stress Hormones""; ""Electrocardiography""; ""Echocardiography""; ""Coronary Angiography and Ventriculography""; ""Cardiovascular magnetic resonance imaging""; ""Myocardial Single Photon Emission Computed Tomography""
327   $a""Endomyocardial Biopsies""""Pathophysiological Mechanisms""; ""Multivessel Epicardial Coronary Artery Spasm""; ""Coronary Microvascular Impairment""; ""Catecholamine Cardiotoxicity""; ""Therepeutic Options""; ""Prognosis""; ""CONCLUSION""; ""REFERENCES""; ""OXIDATIVE STRESS AND HEART FAILURE: STILL A VIABLE THERAPEUTIC TARGET?""; ""ABSTRACT""; ""INTRODUCTION""; ""SOURCES OF OXIDATIVE STRESS IN HEART FAILURE""; ""PHYSIOLOGICAL IMPORTANCE OF REDOX SIGNALING""; ""IMPLICATIONS FOR STEM CELL THERAPY""; ""REDOX-SMART DRUG DESIGN FOR HEART FAILURE""; ""CONCLUSION AND PERSPECTIVES""
327   $a""ACKNOWLEDGEMENT""
410  0$aCardiology research and clinical developments series.
606   $aCongestive heart failure
606   $aHeart failure
615  0$aCongestive heart failure.
615  0$aHeart failure.
676   $a616.1/29
701   $aGarcia$b Josias E$01720506
701   $aWright$b Victoro R$01720507
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910809037403321
996   $aCongestive heart failure$94119189
997   $aUNINA